BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32700756)

  • 1. Mannose shows antitumour properties against lung cancer via inhibiting proliferation, promoting cisplatin‑mediated apoptosis and reducing metastasis.
    Wang Y; Xie S; He B
    Mol Med Rep; 2020 Oct; 22(4):2957-2965. PubMed ID: 32700756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion.
    Wu HJ; Wu HB; Zhao YQ; Chen LJ; Zou HZ
    Oncol Rep; 2016 Jul; 36(1):324-32. PubMed ID: 27222242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisol B 23‑acetate inhibits the viability and induces apoptosis of non‑small cell lung cancer cells via PI3K/AKT/mTOR signal pathway.
    Liu Y; Xia XC; Meng LY; Wang Y; Li YM
    Mol Med Rep; 2019 Aug; 20(2):1187-1195. PubMed ID: 31173235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway.
    Wu S; Peng L; Sang H; Ping Li Q; Cheng S
    J BUON; 2018; 23(5):1407-1412. PubMed ID: 30570866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
    Aldonza MB; Hong JY; Bae SY; Song J; Kim WK; Oh J; Shin Y; Lee SH; Lee SK
    PLoS One; 2015; 10(6):e0127841. PubMed ID: 26098947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3Kα inhibitor DFX24 suppresses tumor growth and metastasis in non-small cell lung cancer via ERK inhibition and EPHB6 reactivation.
    Fan YH; Ding HW; Kim D; Liu JY; Hong JY; Xu YN; Wang D; Yang XS; Lee SK
    Pharmacol Res; 2020 Oct; 160():105147. PubMed ID: 32814167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
    Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
    Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
    Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
    Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma.
    Gong K; Miao S; Yang L; Wu Y; Guo J; Chen W; Dai J; Du J; Xi S
    Pharm Biol; 2020 Dec; 58(1):1044-1054. PubMed ID: 33027592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway.
    Mao Z; Shen X; Dong P; Liu G; Pan S; Sun X; Hu H; Pan L; Huang J
    Phytomedicine; 2019 Aug; 61():152809. PubMed ID: 31035050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway.
    Wang Y; Hou Y; Hou L; Wang W; Li K; Zhang Z; Du B; Kong D
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cediranib Induces Apoptosis, G1 Phase Cell Cycle Arrest, and Autophagy in Non-Small-Cell Lung Cancer Cell A549 In Vitro.
    Guo M; Liu Z; Si J; Zhang J; Zhao J; Guo Z; Xie Y; Zhang H; Gan L
    Biomed Res Int; 2021; 2021():5582648. PubMed ID: 33860036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
    Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
    Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.